Fluslide 20 Capsule contains Fluoxetine 20mg, a selective serotonin reuptake inhibitor (SSRI) designed to manage major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and panic disorders. By increasing serotonin levels in the brain, it helps regulate mood, reduce anxiety, and improve overall mental well-being.
This higher-strength formulation is particularly useful for patients requiring enhanced symptom control or long-term therapy. It provides consistent therapeutic effects while maintaining tolerability, making it a preferred choice among psychiatrists and mental health specialists.
Fluslide 20 Capsule falls under the neuropsychiatric segment, ensuring robust demand across hospitals, psychiatric clinics, and PCD pharma franchise networks. Its effectiveness, patient-friendly dosing, and reputation for reliability offer franchise partners a competitive advantage in the mental health pharmaceutical market.
With increasing recognition of mental health issues and growing demand for effective antidepressants, Flurot 20 Tablet presents a high-margin B2B opportunity. It is ideal for PCD distribution, hospital supply, and export, making it a valuable addition to any pharma portfolio focusing on neuropsychiatric therapies.